Successful atorvastatin treatment of pulmonary alveolar proteinosis in a child with GM-CSF receptor deficiency

Pediatr Pulmonol. 2024 Jun;59(6):1777-1780. doi: 10.1002/ppul.26946. Epub 2024 Feb 27.
No abstract available

Keywords: child; interstitial lung disease; statin.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Atorvastatin* / therapeutic use
  • Child
  • Female
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Pulmonary Alveolar Proteinosis* / drug therapy
  • Pyrroles / therapeutic use
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor* / genetics
  • Treatment Outcome

Substances

  • Atorvastatin
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Heptanoic Acids
  • Pyrroles

Grants and funding